Hiroaki Ohnishi

1.0k total citations
52 papers, 774 citations indexed

About

Hiroaki Ohnishi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroaki Ohnishi has authored 52 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Molecular Biology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroaki Ohnishi's work include Lung Cancer Treatments and Mutations (10 papers), Acute Myeloid Leukemia Research (8 papers) and Lung Cancer Research Studies (6 papers). Hiroaki Ohnishi is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Acute Myeloid Leukemia Research (8 papers) and Lung Cancer Research Studies (6 papers). Hiroaki Ohnishi collaborates with scholars based in Japan and United States. Hiroaki Ohnishi's co-authors include Takashi Watanabe, Kouki Ohtsuka, Satsuki Matsushima, Terukazu Tanaka, Yoshitsugu Kubota, Akira Kitanaka, Toshihiko Ishida, Tomoyuki Goya, Fumio Bessho and Yasuhide Hayashi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Hiroaki Ohnishi

51 papers receiving 763 citations

Peers

Hiroaki Ohnishi
Alessandra Tosolini United States
Susanne A. Gatz United Kingdom
Peter Moosmann Switzerland
Nanette McAtee United States
Michael Harvey Australia
Alessandra Tosolini United States
Hiroaki Ohnishi
Citations per year, relative to Hiroaki Ohnishi Hiroaki Ohnishi (= 1×) peers Alessandra Tosolini

Countries citing papers authored by Hiroaki Ohnishi

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Ohnishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ohnishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ohnishi more than expected).

Fields of papers citing papers by Hiroaki Ohnishi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ohnishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ohnishi. The network helps show where Hiroaki Ohnishi may publish in the future.

Co-authorship network of co-authors of Hiroaki Ohnishi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Ohnishi. A scholar is included among the top collaborators of Hiroaki Ohnishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Ohnishi. Hiroaki Ohnishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kishino, Tomonori, et al.. (2024). Close relationships between neck and upper-back stiffness and transverse cervical artery flow velocity. European Journal of Applied Physiology. 124(6). 1925–1931. 1 indexed citations
2.
Ohtsuka, Kouki, Masachika Fujiwara, Masao Yoshida, et al.. (2023). A rad50 germline mutation induces tumorigenesis and ataxia-telangiectasia phenotype in a transparent medaka model. PLoS ONE. 18(4). e0282277–e0282277. 1 indexed citations
3.
Ohtsuka, Kouki, et al.. (2021). Establishing an internal quality control method for the stable extraction of nucleic acids of severe acute respiratory syndrome coronavirus 2 and RT‐PCR‐based detection. Journal of Clinical Laboratory Analysis. 35(11). e23998–e23998. 1 indexed citations
4.
Ozaki, Ryo, Miki Miura, Daisuke Saito, et al.. (2021). Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis. BMC Gastroenterology. 21(1). 197–197. 15 indexed citations
5.
Ohnishi, Hiroaki, Tadahiko Masaki, Kouki Ohtsuka, et al.. (2014). Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation. Oncology Reports. 32(1). 57–64. 9 indexed citations
6.
Ohnishi, Hiroaki, Tadahiko Masaki, Kouki Ohtsuka, et al.. (2014). Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS. Cancer Chemotherapy and Pharmacology. 73(4). 749–757. 16 indexed citations
7.
Ohnishi, Hiroaki, Junko Sano, Tomonori Kishino, et al.. (2012). Effect of Carryover of Clot Activators on Coagulation Tests During Phlebotomy. American Journal of Clinical Pathology. 137(6). 900–903. 6 indexed citations
9.
Ohta, Yasuhiko, Akira Kitanaka, Keichiro Mihara, et al.. (2011). Expression of CD38 with intracellular enzymatic activity: a possible explanation for the insulin release induced by intracellular cADPR. Molecular and Cellular Biochemistry. 352(1-2). 293–299. 11 indexed citations
10.
Imataki, Osamu, Hiroaki Ohnishi, Genji Yamaoka, et al.. (2010). Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse. International Journal of Clinical Oncology. 15(1). 112–115. 13 indexed citations
11.
Imataki, Osamu, Yoshitsugu Kubota, Hiroaki Ohnishi, et al.. (2010). Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis. Supportive Care in Cancer. 19(10). 1657–1665. 3 indexed citations
12.
Fukumoto, Tetsuya, Yoshitsugu Kubota, Akira Kitanaka, et al.. (2009). Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells. Cellular Signalling. 21(12). 1775–1783. 11 indexed citations
13.
Kitanaka, Akira, Yoshitsugu Kubota, Osamu Imataki, et al.. (2008). Intravascular large B‐cell lymphoma with FDG accumulation in the lung lacking CT/67gallium scintigraphy abnormality. Hematological Oncology. 27(1). 46–49. 22 indexed citations
14.
Ohtsuka, Kouki, Hiroaki Ohnishi, Masachika Fujiwara, et al.. (2007). Abnormalities of epidermal growth factor receptor in lung squamous‐cell carcinomas, adenosquamous carcinomas, and large‐cell carcinomas. Cancer. 109(4). 741–750. 59 indexed citations
15.
Ohtsuka, Kouki, Hiroaki Ohnishi, Hiroshi Nogami, et al.. (2006). Clinico-Pathological and Biological Significance of Tyrosine Kinase Domain Gene Mutations and Overexpression of Epidermal Growth Factor Receptor for Lung Adenocarcinoma. Journal of Thoracic Oncology. 1(8). 787–795. 30 indexed citations
17.
Kubota, Yoshitsugu, et al.. (2006). Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells. Leukemia Research. 30(11). 1391–1398. 18 indexed citations
18.
Kotb, Malak, et al.. (1993). Preservation of the Specificity of Superantigen to T Cell Receptor Vβ Elements in the Absence of MHC Class II Molecules. Cellular Immunology. 152(2). 348–357. 8 indexed citations
20.
Ohnishi, Hiroaki, et al.. (1989). Role of the Kidney in Metabolic Change of Interleukin-2. Tumor Biology. 10(4). 202–214. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026